Bentham Science Logo

Contents

Current Cancer Drug Targets, Volume 16 - Number 3


Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy

, 16(3): 200 - 208

Martin Andrs, Jan Korabecny, Eugenie Nepovimova, Daniel Jun, Zdenek Hodny and Kamil Kuca


DOI: 10.2174/156800961603160206122927




Potential Therapeutic Approaches for the Treatment of Acute Myeloid Leukemia with AML1-ETO Translocation

, 16(3): 215 - 225

Rashi Arora, Sharad Sawney and Daman Saluja


DOI: 10.2174/1568009616666151113120146



Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models

, 16(3): 226 - 237

Cristina P.R. Xavier, Milica Pesic and M. Helena Vasconcelos


DOI: 10.2174/1568009616666151113120705



Role of Liprins in the Regulation of Tumor Cell Motility and Invasion

, 16(3): 238 - 248

Sara Chiaretti and Ivan de Curtis


DOI: 10.2174/156800961603160206124103




Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma

, 16(3): 261 - 274

Marilù Fanelli, Claudia Maria Hattinger, Serena Vella, Elisa Tavanti, Francesca Michelacci, Beth Gudeman, Daryl Barnett, Piero Picci and Massimo Serra


DOI: 10.2174/1568009616666151106120434



The Novel VEGF121-VEGF165 Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1α-VEGF165/Lon Signaling Through PI3K-AKT-mTOR Pathway

, 16(3): 275 - 286

Jui-Ling Tsai, Yu-May Lee, Chien-Yuan Pan and Alan Yueh-Luen Lee


DOI: 10.2174/156800961603160206125352




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science